BPIQ Elite

Our HF Favs portfolio typically holds between 8 to 50 tickers, based on the top combined holdings of major biopharma hedge funds, It is primarily updated quarterly based on the release of hedge fund holdings.

Our Run-Up portfolio invests in 5 to 25 top holdings of hedge funds that have upcoming key clinical readouts. The portfolio invests ahead of, and sometimes through, key clinical readouts, to try to take advantage of run-ups of the underlying stock into these events. You can access percent holdings by ticker, trade logs, and upcoming readouts for the companies in this portfolio.